Payer PolicyActive
CMM-207: Epidural Adhesiolysis
EVICORE-MSK_ADVANCED-0438C7D3
EviCore by Evernorth
Effective: February 14, 2020
Updated: January 13, 2026
created · Dec 5, 2025
Policy Summary
Epidural adhesiolysis (catheter- or endoscopically performed), including percutaneous lysis with solution or mechanical means and neurolytic epidural/subarachnoid injections, is considered experimental/investigational/unproven and not covered (CPT 62263, 62264, 62280–62282 listed). No covered indications or specific documentation requirements are provided; final reimbursement/authorization determinations are made by the individual health plan.
Coverage Criteria Preview
Key requirements from the full policy
"None — There are no covered indications listed. The guideline states: 'There is insufficient scientific evidence to support the use of epidural adhesiolysis, performed by catheter or endoscopically..."
Sign up to see full coverage criteria, indications, and limitations.